Provided by Tiger Trade Technology Pte. Ltd.

BriaCell Therapeutics Corp.

4.18
+0.01000.24%
Post-market: 4.14-0.0400-0.96%19:24 EST
Volume:195.88K
Turnover:808.34K
Market Cap:25.96M
PE:-0.12
High:4.24
Open:4.13
Low:4.05
Close:4.17
52wk High:98.20
52wk Low:4.05
Shares:6.21M
Float Shares:6.00M
Volume Ratio:0.96
T/O Rate:3.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-33.7856
EPS(LYR):-62.1862
ROE:-444.07%
ROA:-161.64%
PB:2.60
PE(LYR):-0.07

Loading ...

Jan 15, 2026

Major Issues Report

Form 8-K - Current report
Dec 29, 2025

Major Issues Report

Form 8-K - Current report
Dec 23, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 23, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 16, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 26, 2025

Major Issues Report

Form 8-K - Current report
Aug 01, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 16, 2025

Major Issues Report

Form 8-K - Current report
Jul 15, 2025

Correspondence

Form CORRESP - Correspondence
Jul 15, 2025

Correspondence

Form CORRESP - Correspondence
Jul 15, 2025

Correspondence

Form CORRESP - Correspondence
Jul 15, 2025

Correspondence

Form CORRESP - Correspondence
Jul 12, 2025

Correspondence

Form CORRESP - Correspondence
Jul 12, 2025

Correspondence

Form CORRESP - Correspondence
Jul 11, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 10, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 09, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 09, 2025

Correspondence

Form CORRESP - Correspondence